Click to go to next articleClick to scroll back to the top
Share on FacebookShare on TwitterShare on Linkedin
Click to go to previous article
Houston Methodist is committed to attracting highly talented leaders, scientists, innovators and teachers. We are pleased to introduce those who have joined our organization since early 2020.
Miguel Cainzos-Achirica MD, PhD, MPH,
associate director, Cardiovascular Disease Prevention Research, Department of Cardiology, DeBakey Heart & Vascular Center, joined Houston Methodist in May 2020. He formerly worked at the Cicccarone Center for the Prevention of Cardiovascular Disease at Johns Hopkins Medicine, where he served as a preventive cardiologist, epidemiologist, population health expert, and outcomes and data scientist.
Francisco Altamirano, PhD
Francisco Altamirano, PhD,
joined the DeBakey Heart & Vascular Center in January 2020 as the director of the electrophysiology lab, Basic Sciences, in collaboration with Miguel Valderrábano, MD, Lois and Carl Davis Centennial Chair and professor of cardiology. Altamirano previously worked in cardiology at the University of Texas Southwestern Medical Center.
Masahiro Fujita, MD, PhD
Masahiro Fujita, MD, PhD,
joined Houston Methodist in January 2020 as director of the positron emission tomography (PET), Translational Imaging Core, and chair of the radiation safety committee at the Research Institute. Fujita is an internationally recognized expert on brain molecular imaging using PET, with expertise in the evaluation of PET tracers and kinetic analysis of brain PET. He aims to guide the development of novel therapies by bridging expertise in basic and clinical sciences. Fujita earned an MD and PhD from Osaka University, Japan, in 1987 and 1992, respectively. In Japan, he earned board certification in nuclear medicine and diagnostic radiology and also obtained qualification as a Type-1 Radiation Protection Supervisor. He previously held positions as a staff scientist at the National Institute of Mental Health from 2002 to 2018 and assistant professor at Yale University from 1999 to 2002.
Charles E. Geyer, Jr., MD, FACP,
joined joined Houston Methodist in January 2020 as deputy director of the Houston Methodist Cancer Center. He has devoted his academic career to the design and conduct of multi-institutional, phase 3 clinical trials in breast cancer with a focus on HER2 targeted therapies. Currently he is co-chair of the NRG Breast Committee and chair of the NSABP Foundation Breast Cancer Committee. Geyer served as study PI on the practice-changing KATHERINE trial and has co-authored over 80 peer-reviewed manuscripts including results of several landmark phase 3 trials conducted by the NSABP.
Farhaan Vahidy, MBBS, PhD, MPH,
joined the Center for Outcomes Research (COR) in January 2020 as associate director and the division chief of Population Health Science & Health Services Research. He will lead the development of learning health care systems models utilizing artificial intelligence and machine learning for rapid integration of scientifically robust evidence into health care practice. He will serve as a key leader at the COR, participating in strategic planning, implementation and mentoring COR’s scientists and research staff. Vahidy was previously an associate professor of neurology at the McGovern Medical School (UTHealth) where he directed the Data Management and Analysis Core and the Division of Population Health and Health Services Research for UTHealth's Institute for Stroke and Cerebrovascular Diseases.
Jing Yang, PhD,
has joined Houston Methodist as a scientist in the Center for Translational Research in Hematological Malignancies. She joins the Houston Methodist Academic Institute from the University of Texas MD Anderson Cancer Center, where she was an associate professor in the Department of Lymphoma and Myeloma
Sign up for our monthly newsletter
Sign up
Follow us
Copyright 2021. Houston Methodist, Houston, TX. All rights reserved.